Abstract
Microarray technology is expanding rapidly providing an extensive as well as promising source of data for better addressing complex questions involving biological processes. The ever increasing number and publicly available gene expression studies of human and other organisms provide strong motivation to carry out cross-study analyses. Besides, microarray technology provides several platforms to investigators that include arrays from commercial vendors like Affymetrix® (Santa Clara, CA, USA), Agilent® (Palo Alto, CA, USA), and other proprietorial arrays of various laboratories. Integration of multiple studies that are based on the same technological platform, or, combining data from different array platforms carries the potential towards higher accuracy, consistency and robust information mining. The integrated result often allows constructing a more complete and broader picture.
In this work, we highlight as well as exemplify two frameworks of microarray data integration approaches that are in practice. This follows a discussion on the important issues that may influence any microarray data integration attempt. The review, in general, intends to serve as a starting point for those interested in exploring this area of microarray study, while realizing the pertinent issues underneath.
Keywords: Data integration, issues, microarrays, microarray technology, review.
Current Bioinformatics
Title: Microarray Data Integration: Frameworks and a List of Underlying Issues
Volume: 5 Issue: 4
Author(s): Chintanu Kumar Sarmah and Sandhya Samarasinghe
Affiliation:
Keywords: Data integration, issues, microarrays, microarray technology, review.
Abstract: Microarray technology is expanding rapidly providing an extensive as well as promising source of data for better addressing complex questions involving biological processes. The ever increasing number and publicly available gene expression studies of human and other organisms provide strong motivation to carry out cross-study analyses. Besides, microarray technology provides several platforms to investigators that include arrays from commercial vendors like Affymetrix® (Santa Clara, CA, USA), Agilent® (Palo Alto, CA, USA), and other proprietorial arrays of various laboratories. Integration of multiple studies that are based on the same technological platform, or, combining data from different array platforms carries the potential towards higher accuracy, consistency and robust information mining. The integrated result often allows constructing a more complete and broader picture.
In this work, we highlight as well as exemplify two frameworks of microarray data integration approaches that are in practice. This follows a discussion on the important issues that may influence any microarray data integration attempt. The review, in general, intends to serve as a starting point for those interested in exploring this area of microarray study, while realizing the pertinent issues underneath.
Export Options
About this article
Cite this article as:
Kumar Sarmah Chintanu and Samarasinghe Sandhya, Microarray Data Integration: Frameworks and a List of Underlying Issues, Current Bioinformatics 2010; 5 (4) . https://dx.doi.org/10.2174/157489310794072517
DOI https://dx.doi.org/10.2174/157489310794072517 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
OA-4 Inhibits Osteoclast Formation and Bone Resorption via Suppressing RANKL Induced P38 Signaling Pathway
Current Medicinal Chemistry Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics
Current Clinical Pharmacology Eco-friendly Synthesis of Pyrido[2,3-d]pyrimidine Analogs and Their Anticancer and Tyrosine Kinase Inhibition Activities
Anti-Cancer Agents in Medicinal Chemistry Comparison of Paraben Stability in Human and Rat Skin
Drug Metabolism Letters Endogenous and Exogenous Ligands of Aryl Hydrocarbon Receptor: Current State of Art
Current Drug Metabolism Characterization of Cepharanthin Nanosuspensions and Evaluation of Their In Vitro Activity for the HepG2 Hepatocellular Carcinoma Cell Line
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth
Anti-Cancer Agents in Medicinal Chemistry DoE Based Optimization and Development of Spray-Dried Chitosan-Coated Alginate Microparticles Loaded with Cisplatin for the Treatment of Cervical Cancer
Current Molecular Pharmacology Actionable Nutrigenetics for Genetically Based Diseases? A New Critical Path to P4 Medicine
Current Pharmacogenomics and Personalized Medicine Graphical Abstracts
Current Drug Delivery Recent Advances in Radiation Therapy of Cancer Cells: A Step towards an Experimental and Systems Biology Framework
Current Radiopharmaceuticals The Other Side of the Opioid Story: Modulation of Cell Growth and Survival Signaling
Current Medicinal Chemistry Seeking the 5th Base of DNA Using Chromatographic Methods of Analysis
Current Organic Chemistry Vitamin D Analogs as Modulators of Vitamin D Receptor Action
Current Topics in Medicinal Chemistry Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance
Current Medicinal Chemistry Sex Hormones and their Analogues in Neuroimmune Biology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Recent Advances in the Development of Novel Therapeutics Targeting Dendritic Cells
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery CASC15: A Tumor-Associated Long Non-Coding RNA
Current Pharmaceutical Design Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain
Current Pharmaceutical Design Rational Identification of Enoxacin as a Novel V-ATPase-Directed Osteoclast Inhibitor
Current Protein & Peptide Science